The Institute of Genetic and Regenerative Medicine NAMS Ukraine is the state-run research institution, aiming at the development and introduction of newest gene and cell technologies into basic science and practical medicine.

The Institute is run by Prof. Gennadii M. Butenko, a Full member of the NAMS Ukraine and a Corresponding member of the NAS Ukraine.

In conformity with the main research directions, the Institute has 8 research laboratories which are comprised into the following three departments:

• Department of Genetic Diagnostics headed by the Corresponding Member of Academician of the NAMS Ukraine Prof. Natalia Gorovenko; 
• Department of Gene Technologies headed by Olena Deryabina, PhD; 
• Department of Cell and Tissue Technologies headed by Prof. Gennadii Butenko, Academician of the NAMS Ukraine.

The Institute of Genetic and Regenerative Medicine has been established with the aim of comprehensive development of basic and applied research into genetic and regenerative medicine issues.

 

 

Our major research directions

• Basic research into the mechanisms of genetic modification of cells and organisms;
• Development and application of newer gene technologies for creating genetically modified experimental models, cells and organisms; introduction of newer biotechnological products and models for pharmacological and pharmaco-genetic investigations;
• Experimental study of the ways and mechanisms of purpose-designed differentiation of adult organism’s stem cells for their further therapeutic use within in regenerative medicine;
• Study on using embryonic and fetal stem cells and cord blood stem cells for a further creation of the differentiated cell and tissue structures for restitution of injured tissues and organs;
• Genome studies in humans with various diseases, marker genes polymorphism research in cardio-vascular, neurodegenerative and immune-dependent diseases, malignancies, osteoporosis, diabetes mellitus, etc;
• Early disease diagnostics and prevention using genetically substantiated methods;
• Essential in the Institute activity is its participation in developing ethical principles for using stem cells, and regenerative and genetic technologies in medical practices.